World's Best Scientists 2026 revealed!
Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
162
Citations
97727
World Ranking
717
National Ranking
24

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Daniel J. Drucker is affiliated with the Lunenfeld-Tanenbaum Research Institute in Canada and has contributed extensively to the fields of medicine, biochemistry, genetics, and molecular biology. Their main research focus lies in endocrinology, diabetes, and metabolism, with significant work also conducted in surgery, molecular biology, physiology, and epidemiology.

The core topics of Drucker's research include diabetes treatment and management, pancreatic function and diabetes, metabolism related to diabetes and cancer, diet and metabolism studies, pharmacology and obesity treatment, receptor mechanisms and signaling, as well as neuropeptides and animal physiology.

Recent papers authored by Drucker cover several key areas, with notable publications including:

  • Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications (2020, Endocrine Reviews)
  • GLP-1 Physiology Informs the Pharmacotherapy of Obesity (2021, Molecular Metabolism)
  • Diabetes, Obesity, Metabolism, and SARS-CoV-2 Infection: The End of the Beginning (2021, Cell Metabolism)

Drucker's frequent coauthors are Laurie L. Baggio, Chi Kin Wong, Jacqueline A. Koehler, Dianne Matthews, and Randy J. Seeley.

This scientist has published predominantly in the following venues:

  • Molecular Metabolism
  • Cell Metabolism
  • Endocrine Reviews
  • Diabetes
  • JCI Insight

Best Publications

  • The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

    Daniel J Drucker;Michael A Nauck

  • Biology of Incretins: GLP-1 and GIP

    Laurie L. Baggio;Daniel J. Drucker

  • The biology of incretin hormones.

    Daniel J. Drucker

  • Glucagon-like peptide 1 (GLP-1)

    T.D. Müller;B. Finan;S.R. Bloom;D. D'Alessio

  • Normalization of obesity-associated insulin resistance through immunotherapy.

    Shawn Winer;Yin Chan;Geoffrey Paltser;Dorothy Truong

  • Pharmacology, physiology, and mechanisms of incretin hormone action

    Jonathan E. Campbell;Daniel J. Drucker

  • FTO Obesity Variant Circuitry and Adipocyte Browning in Humans

    Melina Claussnitzer;Simon N. Dankel;Kyoung Han Kim;Gerald Quon

  • Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

    Daniel J. Drucker

  • Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.

    Daniel J Drucker;John B Buse;Kristin Taylor;David M Kendall

  • Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

    Kiwon Ban;M. Hossein Noyan-Ashraf;M. Hossein Noyan-Ashraf;Judith Hoefer;Judith Hoefer;Steffen-Sebastian Bolz

  • Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

    Daniel J. Drucker;Jacques Philippe;Svetlana Mojsov;William L. Chick

  • Induction of intestinal epithelial proliferation by glucagon-like peptide 2

    D J Drucker;P Erlich;S L Asa;P L Brubaker

  • Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

    Matthew J During;Lei Cao;David S Zuzga;Jeremy S Francis

  • Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

    L A Scrocchi;T J Brown;N MaClusky;P L Brubaker

  • Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

    Helga Ellingsgaard;Irina Hauselmann;Beat Schuler;Abdella M Habib

  • Predicting cardiac complications in patients undergoing non-cardiac surgery

    Detsky As;Abrams Hb;McLaughlin;Drucker Dj

  • Enhancing Incretin Action for the Treatment of Type 2 Diabetes

    Daniel J. Drucker

  • Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis

    Yazhou Li;Tanya Hansotia;Bernardo Yusta;Frederic Ris

  • Incretin-based therapies for type 2 diabetes mellitus.

    Julie A. Lovshin;Daniel J. Drucker

  • The role of gut hormones in glucose homeostasis

    Daniel J. Drucker

Frequent Co-Authors

Patricia L. Brubaker
Patricia L. Brubaker University of Toronto
Sylvia L. Asa
Sylvia L. Asa Case Western Reserve University
Richard D. DiMarchi
Richard D. DiMarchi Indiana University
Randy J. Seeley
Randy J. Seeley University of Michigan–Ann Arbor
Joel F. Habener
Joel F. Habener Harvard University
Yutaka Seino
Yutaka Seino Kyoto University
Matthias H. Tschöp
Matthias H. Tschöp Technical University of Munich
Jens J. Holst
Jens J. Holst University of Copenhagen
Frans Schuit
Frans Schuit KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always mean following the traditional path to an MD. Many students opt for flexible, online options that can kickstart their healthcare careers or advance them further. If you’re looking for a faster route into nursing, you may be interested in 9 month lpn program options, which allow you to become a Licensed Practical Nurse in less than a year.

For those wishing to specialize further, the fastest post master's pmhnp programs provide a streamlined path for qualified nurses to become Psychiatric Mental Health Nurse Practitioners.

Careers in healthcare management are also growing rapidly. Earning an online health management degree can open doors to administrative and leadership roles in hospitals and clinics. For those seeking further advancement, affordable mha online programs offer a cost-effective way to gain comprehensive management skills and move up in the healthcare sector.

These varied pathways each provide unique opportunities—whether you’re starting out, reskilling, or aiming for leadership in healthcare.

Best Scientists Citing Daniel J. Drucker

Trending Scientists